针对肝细胞癌的向治疗的全球趋势:2008年至2022年间的一项图书统计和可视化研究
Xuan-Ang Yang1, Rong Jin1, Lei-Ming Zhang1
1Health Science Center, Ningbo University, Ningbo, Zhejiang Province, China.
Medicine
|September 1, 2023
概括
本文献分析揭示了针对肝细胞癌 (HCC) 向治疗的研究趋势日益增长. 临床研究正在成为这一领域的关键未来方向.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 图书统计学 图书统计学
背景情况:
- 肝细胞癌 (HCC) 是一种流行癌症,预后不佳.
- 向治疗为晚期HCC提供了有效的治疗方法.
- 之前没有对HCC的向疗法进行过文献计量分析.
研究的目的:
- 评估针对HCC的向治疗的当前状态和未来研究趋势.
- 引导未来的学者走向热门的主题和研究领域.
- 为该领域提供全面的文献统计概述.
主要方法:
- 从2008年到2022年,对文献进行了图书统计分析.
- 数据来源于科学网络 (WoS).
- VOSviewer用于可视化文献联结,共同作者,共同引用和共同发生.
主要成果:
- 分析了10,779篇论文,显示出版物的年度增长一直持续.
- 中国在出版量方面处于领先地位;美国的H指数最高.
- 研究集中在五个主要主题:基因表达,机制,纳米粒子,向药物和临床研究.
结论:
- 预计针对HCC的向治疗领域将大幅扩大.
- "临床研究"被认为是未来重要的研究领域.
- 其他子领域可能与临床研究一起呈现平衡的发展.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.9K
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
869
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
